Israelis receive a Pfizer-BioNTech COVID-19 vaccine from medical professionals at a vaccination center set up on a mall parking lot in Givataim, Israel, during a nationwide lockdown to curb the spread of the virus, on Jan. 20.

Israel paid a premium, locked in an early supply of Pfizer-BioNTech vaccines and agreed to share data from Israel’s centralized trove of medical statistics. Privacy advocates have some misgivings.

(Image credit: Oded Balilty/AP)

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

Forgot your details?